These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 33486379)
1. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379 [TBL] [Abstract][Full Text] [Related]
2. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814 [TBL] [Abstract][Full Text] [Related]
4. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2. Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054 [TBL] [Abstract][Full Text] [Related]
5. A role of glycation and methylation for SARS-CoV-2 infection in diabetes? Sartore G; Ragazzi E; Faccin L; Lapolla A Med Hypotheses; 2020 Nov; 144():110247. PubMed ID: 33254553 [TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart. Bois MC; Boire NA; Layman AJ; Aubry MC; Alexander MP; Roden AC; Hagen CE; Quinton RA; Larsen C; Erben Y; Majumdar R; Jenkins SM; Kipp BR; Lin PT; Maleszewski JJ Circulation; 2021 Jan; 143(3):230-243. PubMed ID: 33197204 [TBL] [Abstract][Full Text] [Related]
7. Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Doyle ME; Appleton A; Liu QR; Yao Q; Mazucanti CH; Egan JM Am J Pathol; 2021 Sep; 191(9):1511-1519. PubMed ID: 34102107 [TBL] [Abstract][Full Text] [Related]
8. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
9. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2. Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084 [TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932 [TBL] [Abstract][Full Text] [Related]
11. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
12. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart. Sakamoto A; Kawakami R; Kawai K; Gianatti A; Pellegrini D; Kutys R; Guo L; Mori M; Cornelissen A; Sato Y; Bellasi A; Faggi L; Hong C; Romero M; Guagliumi G; Virmani R; Finn AV Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):542-544. PubMed ID: 33086866 [No Abstract] [Full Text] [Related]
13. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality. Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317 [TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells. Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193 [TBL] [Abstract][Full Text] [Related]